StockData
Zivo Bioscience, Inc. logo

Zivo Bioscience, Inc. (ZIVO) stock

ZIVOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 1/30
$6.80+0.30 (+4.62%)

Close on Oct 19, 2026Market cap $25.96MP/E –Yield –

Zivo Bioscience cash

Cash and short-term investments held at the end of each period.

Zivo Bioscience's cash was $57.22K at Sep 30, 2025. For fiscal 2024 it was $1.54M, up 462.2% from the year before. Over ten years it grew 101.7% a year on average. The highest annual figure on record is $8.90M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2024Dec 31, 2024$1.54M+462.2%
FY2023Dec 31, 2023$274.38K-84.8%
FY2022Dec 31, 2022$1.80M-79.8%
FY2021Dec 31, 2021$8.90M+6357.1%
FY2020Dec 31, 2020$137.86K-60.2%
FY2019Dec 31, 2019$346.11K-11.0%
FY2018Dec 31, 2018$388.89K+22.6%
FY2017Dec 31, 2017$317.14K-37.4%
FY2016Dec 31, 2016$506.99K+2956.2%
FY2015Dec 31, 2015$16.59K+1099.5%
FY2014Dec 31, 2014$1.38K-99.7%
FY2013Dec 31, 2013$493.10K+945.9%
FY2012Dec 31, 2012$47.15K-79.1%
FY2011Dec 31, 2011$225.70K+1346.5%
FY2010Dec 31, 2010$15.60K–
FY2009Dec 31, 2009$0–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2025Sep 30, 2025$57.22K-64.1%
Q2 FY2025Jun 30, 2025$9.82K+298.3%
Q1 FY2025Mar 31, 2025$517.19K+273.0%
Q4 FY2024Dec 31, 2024$1.54M+462.2%
Q3 FY2024Sep 30, 2024$159.40K-89.3%
Q2 FY2024Jun 30, 2024$2.47K-88.3%
Q1 FY2024Mar 31, 2024$138.64K-33.5%
Q4 FY2023Dec 31, 2023$274.38K-84.8%
Q3 FY2023Sep 30, 2023$1.48M-56.2%
Q2 FY2023Jun 30, 2023$21.07K-99.6%
Q1 FY2023Mar 31, 2023$208.60K-96.8%
Q4 FY2022Dec 31, 2022$1.80M-79.8%
Q3 FY2022Sep 30, 2022$3.39M-68.7%
Q2 FY2022Jun 30, 2022$5.08M-53.4%
Q1 FY2022Mar 31, 2022$6.60M+2745.2%
Q4 FY2021Dec 31, 2021$8.90M+6357.1%
Q3 FY2021Sep 30, 2021$10.80M+19412.0%
Q2 FY2021Jun 30, 2021$10.90M+9072.5%
Q1 FY2021Mar 31, 2021$231.94K+2209.4%
Q4 FY2020Dec 31, 2020$137.86K-60.2%
Q3 FY2020Sep 30, 2020$55.37K+258.9%
Q2 FY2020Jun 30, 2020$118.87K+173.0%
Q1 FY2020Mar 31, 2020$10.04K+134.4%
Q4 FY2019Dec 31, 2019$346.11K-11.0%
Q3 FY2019Sep 30, 2019$15.43K-93.2%
Q2 FY2019Jun 30, 2019$43.53K-93.6%
Q1 FY2019Mar 31, 2019$4.29K-95.6%
Q4 FY2018Dec 31, 2018$388.89K+22.6%
Q3 FY2018Sep 30, 2018$228.39K-81.3%
Q2 FY2018Jun 30, 2018$677.99K+2700.7%
Q1 FY2018Mar 31, 2018$98.14K-90.3%
Q4 FY2017Dec 31, 2017$317.14K-37.4%
Q3 FY2017Sep 30, 2017$1.22M+109.2%
Q2 FY2017Jun 30, 2017$24.21K-5.9%
Q1 FY2017Mar 31, 2017$1.01M+288.7%
Q4 FY2016Dec 31, 2016$506.99K+2956.2%
Q3 FY2016Sep 30, 2016$585.28K–
Q2 FY2016Jun 30, 2016$25.73K–
Q1 FY2016Mar 31, 2016$259.23K–
Q4 FY2015Dec 31, 2015$16.59K–

More Zivo Bioscience figures

See a number that looks wrong?